Literature DB >> 19683897

Frequency and characterisation of spontaneous lipiarmycin-resistant Enterococcus faecalis mutants selected in vitro.

Maxime Gualtieri, Audrey Tupin, Konstantin Brodolin, Jean-Paul Leonetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19683897     DOI： 10.1016/j.ijantimicag.2009.07.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  10 in total

1.  The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site.

Authors:  Audrey Tupin; Maxime Gualtieri; Jean-Paul Leonetti; Konstantin Brodolin
Journal:  EMBO J       Date:  2010-06-18       Impact factor: 11.598

2.  Antibiotics trapping transcription initiation intermediates: To melt or to bend, what's first?

Authors:  Konstantin Brodolin
Journal:  Transcription       Date:  2011-03

3.  Genetic basis for daptomycin resistance in enterococci.

Authors:  Kelli L Palmer; Anu Daniel; Crystal Hardy; Jared Silverman; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

4.  Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae.

Authors:  Ed T Buurman; Melinda A Foulk; Ning Gao; Valerie A Laganas; David C McKinney; Demetri T Moustakas; Jonathan A Rose; Adam B Shapiro; Paul R Fleming
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

Review 5.  Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.

Authors:  Jennifer A Leeds
Journal:  Cold Spring Harb Perspect Med       Date:  2016-02-01       Impact factor: 6.915

Review 6.  New target for inhibition of bacterial RNA polymerase: 'switch region'.

Authors:  Aashish Srivastava; Meliza Talaue; Shuang Liu; David Degen; Richard Y Ebright; Elena Sineva; Anirban Chakraborty; Sergey Y Druzhinin; Sujoy Chatterjee; Jayanta Mukhopadhyay; Yon W Ebright; Alex Zozula; Juan Shen; Sonali Sengupta; Rui Rong Niedfeldt; Cai Xin; Takushi Kaneko; Herbert Irschik; Rolf Jansen; Stefano Donadio; Nancy Connell; Richard H Ebright
Journal:  Curr Opin Microbiol       Date:  2011-08-19       Impact factor: 7.934

7.  Multiple roles of the RNA polymerase {beta}' SW2 region in transcription initiation, promoter escape, and RNA elongation.

Authors:  Danil Pupov; Nataliya Miropolskaya; Anastasiya Sevostyanova; Irina Bass; Irina Artsimovitch; Andrey Kulbachinskiy
Journal:  Nucleic Acids Res       Date:  2010-05-10       Impact factor: 16.971

8.  Antimicrobial activities of fidaxomicin.

Authors:  Ellie J C Goldstein; Farah Babakhani; Diane M Citron
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

9.  Semisynthetic Analogs of the Antibiotic Fidaxomicin-Design, Synthesis, and Biological Evaluation.

Authors:  Andrea Dorst; Regina Berg; Christoph G W Gertzen; Daniel Schäfle; Katja Zerbe; Myriam Gwerder; Simon D Schnell; Peter Sander; Holger Gohlke; Karl Gademann
Journal:  ACS Med Chem Lett       Date:  2020-10-14       Impact factor: 4.345

10.  Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts.

Authors:  Hande Boyaci; James Chen; Mirjana Lilic; Margaret Palka; Rachel Anne Mooney; Robert Landick; Seth A Darst; Elizabeth A Campbell
Journal:  Elife       Date:  2018-02-26       Impact factor: 8.140
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.